Average Insider

Where insiders trade, we follow

Hohl Benjamin

CHIEF FINANCIAL OFFICER
CIK: 1882764

All Transactions

DateCompanyTypeSharesPriceValueActions
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)M1,072$0.00$0.00View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S324$49.97$16,190.77View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S369$51.48$18,996.97View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S2,564$52.32$134,143.35View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S2,638$53.38$140,823.04View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S123$53.87$6,626.21View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)M1,072$2.48$2,658.56View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)S1,379$42.78$59,000.51View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)S3,401$43.86$149,179.42View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)S1,238$44.75$55,397.41View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)M6,018$0.00$0.00View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)M6,018$2.48$14,924.64View Details Filing
15 more transactions available โ€” create a free account to see 12 months of history
Version: v26.7.3